Editorial: Noncoding RNAs in neurodegenerative disorders: from current insights and future directions to translational modeling and therapeutic approaches

Yujing Li,Akshay Bhinge,Satoshi Inoue,Gonçalo Garcia

DOI: https://doi.org/10.3389/fnins.2024.1497673

IF: 4.3

2024-10-29

Frontiers in Neuroscience

Abstract:Neurodegenerative disorders (NDs), such as Alzheimer's disease (AD), Parkinson's disease (PD), and 18 amyotrophic lateral sclerosis (ALS), remain major challenges in medicine, characterized by gradual 19 loss of neuronal structure and function (Mo, 2023;Canoy et al., 2024). Many research studies have 20 shed light on the crucial roles of noncoding RNAs (ncRNAs) in the pathogenesis of these diseases, 21 offering new avenues for diagnosis and therapy (Garcia et al., 2021;Canoy et al., 2024). This research 22 topic focuses on the involvement of various ncRNAs, including piRNAs, microRNAs (miRNAs), long 23 noncoding RNAs (lncRNAs), circular RNAs (circRNAs) and competing endogenous RNAs (ceRNAs), 24 in the NDs, as well as exploring future directions for translating these findings into clinical therapies. 25The studies presented in this research topic provide valuable insights into the molecular mechanisms 26 governed by the ncRNAs and their potential to serve as both biomarkers and therapeutic targets. 27In

neurosciences